Prospective Database of Gastrointestinal Stromal Cell Tumors (GISTs)
NCT ID: NCT02147145
Last Updated: 2014-05-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
187 participants
OBSERVATIONAL
2008-08-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Specific Aim 2: To determine if EUS features of GIST, particularly maximum size, change significantly during a surveillance program.
Hypothesis: EUS features of GIST, particularly maximum size, will not change significantly during a surveillance program.
Specific Aim 3: To determine if EGD measures of GIST size correlate well with EUS measures of GIST size.
Hypothesis: EGD measures of GIST size will correlate well with EUS measured of GIST size.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
NCT04557969
Gastrointestinal Stromal Tumors (GIST) Registry
NCT00507273
Prognostic Factors Affecting Survival of Gastric GIST
NCT04269941
Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST
NCT02353052
Long Outcome of Endoscopic Submucosal Dissection for Small Gastrointestinal Stromal Tumors (<2cm)
NCT03082079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observation Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* at least 18 years of age
* able to provide informed consent
Exclusion Criteria
* less than 18 years of age
* unable to provide informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Washington University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northwestern University
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ProGIST 1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.